This company has been marked as potentially delisted and may not be actively trading. Xyratex (XRTX) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesShort InterestTrendsBuy This Stock XRTX vs. SLGL, SYBX, CLRB, CING, BCTX, NRBO, NXTC, ME, GLYC, and MTVAShould you be buying Xyratex stock or one of its competitors? The main competitors of Xyratex include Sol-Gel Technologies (SLGL), Synlogic (SYBX), Cellectar Biosciences (CLRB), Cingulate (CING), BriaCell Therapeutics (BCTX), NeuroBo Pharmaceuticals (NRBO), NextCure (NXTC), 23andMe (ME), GlycoMimetics (GLYC), and MetaVia (MTVA). These companies are all part of the "pharmaceutical preparations" industry. Xyratex vs. Sol-Gel Technologies Synlogic Cellectar Biosciences Cingulate BriaCell Therapeutics NeuroBo Pharmaceuticals NextCure 23andMe GlycoMimetics MetaVia Sol-Gel Technologies (NASDAQ:SLGL) and Xyratex (NASDAQ:XRTX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, valuation, community ranking, profitability, analyst recommendations, earnings and dividends. Does the media prefer SLGL or XRTX? In the previous week, Sol-Gel Technologies had 2 more articles in the media than Xyratex. MarketBeat recorded 2 mentions for Sol-Gel Technologies and 0 mentions for Xyratex. Sol-Gel Technologies' average media sentiment score of 1.27 beat Xyratex's score of 0.00 indicating that Sol-Gel Technologies is being referred to more favorably in the media. Company Overall Sentiment Sol-Gel Technologies Positive Xyratex Neutral Which has more volatility & risk, SLGL or XRTX? Sol-Gel Technologies has a beta of 1.24, meaning that its share price is 24% more volatile than the S&P 500. Comparatively, Xyratex has a beta of 0.64, meaning that its share price is 36% less volatile than the S&P 500. Which has stronger earnings & valuation, SLGL or XRTX? Xyratex has lower revenue, but higher earnings than Sol-Gel Technologies. Sol-Gel Technologies is trading at a lower price-to-earnings ratio than Xyratex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSol-Gel Technologies$11.71M1.11-$27.24M-$0.34-1.37XyratexN/AN/A-$2.16M-$1.35N/A Do institutionals and insiders hold more shares of SLGL or XRTX? 26.2% of Sol-Gel Technologies shares are held by institutional investors. Comparatively, 0.2% of Xyratex shares are held by institutional investors. 66.5% of Sol-Gel Technologies shares are held by company insiders. Comparatively, 6.9% of Xyratex shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the MarketBeat Community prefer SLGL or XRTX? Xyratex received 7 more outperform votes than Sol-Gel Technologies when rated by MarketBeat users. Likewise, 63.41% of users gave Xyratex an outperform vote while only 63.40% of users gave Sol-Gel Technologies an outperform vote. CompanyUnderperformOutperformSol-Gel TechnologiesOutperform Votes14963.40% Underperform Votes8636.60% XyratexOutperform Votes15663.41% Underperform Votes9036.59% Do analysts rate SLGL or XRTX? Sol-Gel Technologies currently has a consensus target price of $5.00, indicating a potential upside of 973.88%. Given Sol-Gel Technologies' stronger consensus rating and higher probable upside, research analysts clearly believe Sol-Gel Technologies is more favorable than Xyratex.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sol-Gel Technologies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Xyratex 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is SLGL or XRTX more profitable? Xyratex has a net margin of 0.00% compared to Sol-Gel Technologies' net margin of -81.75%. Sol-Gel Technologies' return on equity of -27.17% beat Xyratex's return on equity.Company Net Margins Return on Equity Return on Assets Sol-Gel Technologies-81.75% -27.17% -22.49% Xyratex N/A -146.27%-86.83% SummarySol-Gel Technologies beats Xyratex on 12 of the 17 factors compared between the two stocks. Remove Ads Get Xyratex News Delivered to You Automatically Sign up to receive the latest news and ratings for XRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XRTX vs. The Competition Export to ExcelMetricXyratexPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.49M$6.33B$5.25B$7.11BDividend YieldN/A2.84%4.89%4.05%P/E Ratio-0.686.7221.1917.44Price / SalesN/A187.01356.8085.22Price / CashN/A65.6738.1834.64Price / BookN/A5.576.243.79Net Income-$2.16M$141.67M$3.20B$247.10M Xyratex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XRTXXyratex0.2969 of 5 starsN/AN/A-73.9%$3.49MN/A-0.68N/AGap DownSLGLSol-Gel Technologies2.5214 of 5 stars$0.52+0.4%$5.00+857.9%-53.4%$14.54M$11.71M-1.5450SYBXSynlogicN/A$1.23-0.8%N/A-39.7%$14.39M$8,000.00-0.3080Gap DownCLRBCellectar Biosciences1.4224 of 5 stars$0.31-2.6%$12.50+3,971.7%-92.9%$14.15MN/A-0.1810Analyst ForecastCINGCingulate3.0289 of 5 stars$4.35+1.0%$16.00+268.2%+253.3%$13.96MN/A-0.3020Upcoming EarningsAnalyst RevisionNews CoverageGap UpBCTXBriaCell Therapeutics1.1514 of 5 stars$3.68+0.9%$32.00+768.6%-90.6%$13.67MN/A-0.288News CoverageNRBONeuroBo Pharmaceuticals1.113 of 5 stars$1.58+1.0%$10.00+534.9%-60.7%$13.57MN/A0.0010NXTCNextCure3.9495 of 5 stars$0.53+10.6%$3.50+559.1%-81.9%$13.47MN/A-0.2390News CoverageME23andMe1.2467 of 5 stars$0.50-35.3%$9.40+1,787.6%-94.7%$13.36M$208.78M-0.03770Gap DownHigh Trading VolumeGLYCGlycoMimetics1.1898 of 5 stars$0.21-1.4%N/A-93.4%$13.35M$10,000.000.0050News CoverageGap DownMTVAMetaVia1.9832 of 5 stars$1.54-2.2%$12.00+679.2%N/A$13.33MN/A0.0010Analyst RevisionNews CoverageGap Up Remove Ads Related Companies and Tools Related Companies SLGL Alternatives SYBX Alternatives CLRB Alternatives CING Alternatives BCTX Alternatives NRBO Alternatives NXTC Alternatives ME Alternatives GLYC Alternatives MTVA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XRTX) was last updated on 4/5/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredIt’s Time to Buy Elon’s “ChatGPT Killer”Elon Musk’s new AI model is blowing everyone’s mind. It has been called “a game-changer in AI innovation”.....Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xyratex Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Xyratex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy XRTX Stock Free XRTX Stock Alerts